| |
|
|
| Name: |
BVF INC/IL |
| City: |
SAN FRANCISCO |
| State: |
CA |
| Zip: |
94104 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
53 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
MLTX |
Multisys Language Solutions... |
1 |
- |
$0.00 |
$771,683,000 |
19,751,284 |
31.45% |
-297,849,000 |
0 |
31.406 |
N/A |
|
|
AXSM |
Axsome Therapeutics, Inc. |
2 |
- |
$110.73 |
$197,130,000 |
1,690,221 |
8.03% |
79,686,000 |
302,157 |
3.572 |
N/A |
|
|
RVMD |
Revolution Medicines, Inc. |
3 |
- |
$38.50 |
$176,177,000 |
4,982,384 |
7.18% |
-6,708,000 |
801,205 |
2.931 |
N/A |
|
|
KYMR |
Kymera Therapeutics, Inc. |
4 |
- |
$0.00 |
$141,278,000 |
5,161,801 |
5.76% |
-66,381,000 |
0 |
7.304 |
N/A |
|
|
MIRM |
Mirum Pharmaceuticals, Inc. |
5 |
- |
$0.00 |
$125,983,000 |
2,796,513 |
5.13% |
10,347,000 |
0 |
5.217 |
N/A |
|
|
PTGX |
Protagonist Therapeutics, Inc |
6 |
- |
$52.83 |
$124,528,000 |
2,575,015 |
5.08% |
51,187,000 |
675,000 |
4.027 |
N/A |
|
|
GHRS |
Gh Research Ord Shs |
7 |
- |
$0.00 |
$97,370,000 |
8,827,712 |
3.97% |
24,569,000 |
-1,572,446 |
18.071 |
N/A |
|
|
XOMA |
XOMA Corporation |
8 |
- |
$27.90 |
$59,452,000 |
2,983,026 |
2.42% |
-36,043,000 |
-650,717 |
26.469 |
Biotechnology |
|
|
IONS |
Ionis Pharmaceuticals Inc |
9 |
- |
$42.38 |
$57,727,000 |
1,913,385 |
2.35% |
57,727,000 |
1,913,385 |
1.211 |
Drug Manufacturers - ... |
|
|
ZYME |
Zymeworks Inc |
10 |
- |
$13.66 |
$51,319,000 |
4,308,935 |
2.09% |
-11,764,000 |
0 |
6.155 |
N/A |
|
|
KURA |
Kura Oncology Inc |
11 |
- |
$6.36 |
$51,177,000 |
7,754,129 |
2.09% |
28,814,000 |
5,186,660 |
9.258 |
N/A |
|
|
CGEM |
Cullinan Oncology Ord Shs |
12 |
- |
$0.00 |
$43,533,000 |
5,750,683 |
1.77% |
-26,510,000 |
0 |
1.321 |
N/A |
|
|
ACIU |
AC Immune SA |
13 |
- |
$2.11 |
$37,068,000 |
19,822,436 |
1.51% |
-15,643,000 |
300,000 |
27.631 |
N/A |
|
|
TYRA |
Tyra Biosciences, Inc. |
14 |
- |
$0.00 |
$36,681,000 |
3,944,194 |
1.5% |
-18,143,000 |
0 |
7.479 |
N/A |
|
|
GLPG |
Galapagos NV - ADR |
15 |
- |
$30.49 |
$36,535,000 |
1,454,422 |
1.49% |
-6,624,000 |
-115,000 |
2.226 |
N/A |
|
|
CELC |
Celcuity Inc. |
16 |
- |
$13.62 |
$35,041,000 |
3,466,000 |
1.43% |
-10,329,000 |
0 |
9.36 |
N/A |
|
|
VERV |
Verve Therapeutics, Inc. |
17 |
- |
$0.00 |
$31,552,000 |
6,904,050 |
1.29% |
-7,387,000 |
0 |
8.585 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
18 |
- |
$18.90 |
$30,663,000 |
1,771,417 |
1.25% |
-17,378,000 |
0 |
2.812 |
N/A |
|
|
XNCR |
Xencor Inc |
19 |
- |
$9.28 |
$29,155,000 |
2,740,141 |
1.19% |
-23,441,000 |
451,381 |
3.045 |
Biotechnology |
|
|
GLUE |
Monte Rosa Therapeutics, Inc. |
20 |
- |
$0.00 |
$26,263,000 |
5,660,132 |
1.07% |
7,078,000 |
2,895,661 |
9.223 |
N/A |
|
|
SEPN |
Septerna, Inc. |
21 |
- |
$11.68 |
$25,454,000 |
4,396,124 |
1.04% |
-30,697,000 |
1,944,100 |
9.901 |
N/A |
|
|
ELDN |
Eledon Pharmaceuticals Ord Shs |
22 |
- |
$3.45 |
$21,334,000 |
6,293,282 |
0.87% |
-4,594,000 |
0 |
15.868 |
N/A |
|
|
CDTX |
Cidara Therapeutics, Inc. |
23 |
- |
$50.88 |
$19,917,000 |
924,642 |
0.81% |
-9,457,000 |
-168,154 |
20.273 |
N/A |
|
|
OLMA |
Olema Pharmaceuticals, Inc. |
24 |
- |
$0.00 |
$19,913,000 |
5,295,893 |
0.81% |
-13,411,000 |
-420,000 |
8.813 |
N/A |
|
|
PVLA |
Palvella Therapeutics Inc |
25 |
- |
$26.94 |
$19,497,000 |
696,555 |
0.79% |
11,138,000 |
0 |
52.769 |
N/A |
|
|
FHTX |
Foghorn Therapeutics Inc. |
26 |
- |
$0.00 |
$19,352,000 |
5,302,000 |
0.79% |
-5,673,000 |
0 |
9.583 |
N/A |
|
|
ITOS |
Iteos Therapeutics, Inc. |
27 |
- |
$0.00 |
$18,358,000 |
3,075,000 |
0.75% |
502,000 |
750,000 |
8.101 |
N/A |
|
|
FDMT |
4d Molecular Therapeutics Inc. |
28 |
- |
$0.00 |
$14,733,000 |
4,561,289 |
0.6% |
-142,000 |
1,890,647 |
7.337 |
N/A |
|
|
EPIX |
ESSA Pharma Inc |
29 |
- |
$0.00 |
$13,823,000 |
8,748,629 |
0.56% |
-1,837,000 |
0 |
19.892 |
Diagnostic Substances |
|
|
ANNX |
Annexon, Inc. |
30 |
- |
$0.00 |
$13,510,000 |
7,000,000 |
0.55% |
-22,400,000 |
0 |
6.084 |
N/A |
|
|
VSTM |
Verastem, Inc. |
31 |
- |
$4.74 |
$12,666,000 |
2,100,468 |
0.52% |
1,807,000 |
0 |
4.668 |
Biotechnology |
|
|
RAPT |
Rapt Therapeutics, Inc. |
32 |
- |
$1.03 |
$11,270,000 |
9,237,556 |
0.46% |
-3,325,000 |
0 |
25.584 |
N/A |
|
|
RPTX |
Repare Therapeutics Inc. |
33 |
- |
$0.00 |
$10,188,000 |
10,333,600 |
0.42% |
-3,349,000 |
0 |
28.119 |
N/A |
|
|
IMUX |
Immunic Inc |
34 |
- |
$0.84 |
$9,704,000 |
8,902,972 |
0.4% |
801,000 |
0 |
9.883 |
N/A |
|
|
AVTX |
Avalo Therapeutics, Inc |
35 |
- |
$0.43 |
$8,304,000 |
1,036,679 |
0.34% |
601,000 |
0 |
0.923 |
N/A |
|
|
THRD |
Third Harmonic Bio, Inc. |
36 |
- |
$5.45 |
$8,234,000 |
2,372,933 |
0.34% |
-16,183,000 |
0 |
5.273 |
N/A |
|
|
VIGL |
Vigil Neuroscience, Inc. |
37 |
- |
$0.00 |
$7,144,000 |
4,013,633 |
0.29% |
4,061,000 |
2,200,000 |
14.198 |
N/A |
|
|
TCRX |
Tscan Therapeutics, Inc. |
38 |
- |
$0.00 |
$6,747,000 |
4,889,474 |
0.27% |
-2,341,000 |
1,900,000 |
11.227 |
N/A |
|
|
MOLN |
Molecular Partners Adr |
39 |
- |
$0.00 |
$5,511,000 |
1,353,968 |
0.22% |
-947,000 |
0 |
4.194 |
N/A |
|
|
IKNA |
Ikena Oncology, Inc. |
40 |
- |
$0.00 |
$5,128,000 |
4,006,564 |
0.21% |
-1,443,000 |
0 |
8.302 |
N/A |
|
|
FBRX |
Forte Biosciences Inc |
41 |
- |
$1.26 |
$4,612,000 |
594,282 |
0.19% |
-8,884,000 |
0 |
1.635 |
N/A |
|
|
ALLK |
Allakos Inc. |
42 |
- |
$0.33 |
$3,767,000 |
16,552,417 |
0.15% |
-16,261,000 |
0 |
19.425 |
N/A |
|
|
CTMX |
Cytomx Therapeutics, Inc. |
43 |
- |
$0.00 |
$3,324,000 |
5,228,461 |
0.14% |
-2,061,000 |
0 |
8.024 |
N/A |
|
|
TENX |
Tenax Therapeutics Inc |
44 |
- |
$0.26 |
$2,224,000 |
339,549 |
0.09% |
122,000 |
0 |
0.76 |
N/A |
|
|
IVA |
Inventiva Adr Representing ... |
45 |
- |
$3.38 |
$2,058,000 |
686,040 |
0.08% |
583,000 |
0 |
1.787 |
N/A |
|
|
GLYC |
Glycomimetics Inc |
46 |
- |
$0.16 |
$2,004,000 |
9,544,262 |
0.08% |
-373,000 |
0 |
19.955 |
N/A |
|
|
SABS |
Sab Biotherapeutics |
47 |
- |
$5.94 |
$1,239,000 |
917,826 |
0.05% |
-2,267,000 |
0 |
2.111 |
N/A |
|
|
NAMS |
Newamsterdam Pharma Ord Shs |
48 |
- |
$0.00 |
$1,209,000 |
59,065 |
0.05% |
1,209,000 |
59,065 |
0.072 |
N/A |
|
|
OVID |
Ovid Therapeutics Inc. |
49 |
- |
$0.42 |
$1,202,000 |
3,853,818 |
0.05% |
-2,396,000 |
0 |
6.075 |
N/A |
|
|
AGIO |
Agios Pharmaceuticals Inc |
50 |
Closed |
$39.53 |
$0 |
0 |
0% |
-35,284,000 |
-1,073,755 |
0 |
N/A |
|
|
ELEV |
Elevation Oncology, Inc. |
53 |
Closed |
$0.38 |
$0 |
0 |
0% |
-1,669,000 |
-2,966,836 |
0 |
N/A |
|
|
ENGN |
Engene Holdings Inc. |
52 |
Closed |
$3.68 |
$0 |
0 |
0% |
-14,005,000 |
-2,106,037 |
0 |
N/A |
|
|
ETNB |
89bio, Inc. |
51 |
Closed |
$10.78 |
$0 |
0 |
0% |
-33,891,000 |
-4,333,885 |
0 |
N/A |
|
